General Pharmaceutical Council issues joint letter with the Competition and Markets Authority to pharmacies on pricing during the COVID-19 pandemic

Letter highlights reports alleging that a small minority of pharmacies are seeking to benefit from the coronavirus pandemic by charging unjustifiably high prices for essential products. It outlines respective roles and expectations as regulators in relation to this issue.


General Pharmaceutical Council